Here, the administration of TFCP to the MCD-induced NAFLD mice enhanced the expression of HNF4α, thus suggesting the anti-NAFLD role of TFCP via modulating the expression of HNF4α and cytokines. The gene discussed is HNF4A; the disease is metabolic dysfunction-associated steatotic liver disease.